Virtus ETF Advisers LLC - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 148 filers reported holding TRANSLATE BIO INC in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$290,000
+57.6%
10,536
-5.6%
0.12%
+52.6%
Q1 2021$184,000
-8.9%
11,160
+1.8%
0.08%
-7.1%
Q4 2020$202,000
-27.9%
10,959
-46.8%
0.08%
-42.9%
Q3 2020$280,000
-33.2%
20,599
-12.0%
0.15%
-25.8%
Q2 2020$419,000
+1.0%
23,395
-43.8%
0.20%
+15.8%
Q1 2020$415,000
+7.0%
41,612
-12.7%
0.17%
+171.4%
Q4 2019$388,00047,6850.06%
Other shareholders
TRANSLATE BIO INC shareholders Q2 2021
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 2,656,517$48,960,00010.98%
Copernicus Capital Management, LLC 12,091$223,0003.48%
FRAZIER MANAGEMENT LLC 2,182,789$40,229,0003.10%
Baupost Group 18,044,239$326,236,0003.01%
DAFNA Capital Management LLC 225,393$4,154,0001.24%
RTW INVESTMENTS, LP 2,978,427$54,892,0000.92%
MARATHON CAPITAL MANAGEMENT 143,275$2,640,0000.78%
Bain Capital Public Equity Management II, LLC 627,387$11,563,0000.59%
Artal Group S.A. 1,200,000$22,116,0000.48%
Birchview Capital, LP 30,000$553,0000.32%
View complete list of TRANSLATE BIO INC shareholders